Deep learning-based CT radiomics for ALK rearrangement status prediction in lung adenocarcinoma.
CT scans with artificial intelligence could identify which lung cancer patients benefit from targeted ALK inhibitor drugs.
This retrospective study developed a deep learning CT radiomics approach to predict ALK gene rearrangement status in lung adenocarcinoma using imaging alone. The model could enable CT-based precision oncology triage, reducing dependence on invasive biopsy for ALK inhibitor eligibility screening.
What the study was
- Study design
- Retrospective study
- Population
- Lung adenocarcinoma patients
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- BMC Cancer
Why it surfaced
CT-based ALK prediction is clinically appealing but limited by retrospective design and single-center origin. BMC Cancer is a solid but not top-tier journal. Preliminary evidence warrants STANDARD tracking.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.